CAD 0.99
(-5.71%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 108.04 Thousand | - | - | - | - | - |
Gross Profit | -108.04 Thousand | - | - | - | - | - |
Operating Expenses | 29.82 Million | 21.58 Million | 13.57 Million | 6.1 Million | 2.59 Million | 3.42 Million |
Selling, General and Administrative Expenses | 29.82 Million | 7.48 Million | 8.01 Million | 2.47 Million | 1.21 Million | 1.19 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 416.09 Thousand | 5.55 Million | 3.62 Million | 1.38 Million | 2.23 Million |
Cost and Expenses | 29.93 Million | 21.58 Million | 13.57 Million | 6.1 Million | 2.59 Million | 3.42 Million |
Operating Income | -29.93 Million | -21.61 Million | -13.57 Million | -6.07 Million | -2.6 Million | -3.42 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 4.84 Million | -428.45 Thousand | -50.94 Thousand | 34.06 Thousand | -6000.00 | -352.93 Thousand |
Earnings before Tax | -25.08 Million | -20.96 Million | -13.52 Million | -5.8 Million | -2.48 Million | -3.06 Million |
Net Income | -25.08 Million | -20.96 Million | -13.46 Million | -5.84 Million | -2.48 Million | -2.71 Million |
Earnings Per Share Basic | -0.25 | -0.28 | -0.23 | -0.16 | -0.26 | -0.41 |
Earnings Per Share Diluted | -0.25 | -0.28 | -0.23 | -0.16 | -0.26 | -0.41 |
Weighted Average Shares Outstanding | 102.2 Million | 74.16 Million | 59.52 Million | 35.54 Million | 9.42 Million | 6.56 Million |
Weighted Average Shares Outstanding (Diluted) | 102.2 Million | 74.16 Million | 59.52 Million | 35.54 Million | 9.42 Million | 6.56 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -24.97 Million | -20.96 Million | -13.52 Million | -5.8 Million | -2.6 Million | -3.06 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 27.94 Thousand | 27.94 Thousand | 26.07 Thousand | 26.07 Thousand | - | - |
Gross Profit | -27.94 Thousand | -27.94 Thousand | -26.07 Thousand | -26.07 Thousand | - | - |
Operating Expenses | 11.68 Million | 1.88 Million | 3.08 Million | 12.49 Million | 21.58 Million | 3.84 Million |
Selling, General and Administrative Expenses | 2.16 Million | 1.88 Million | 3.08 Million | 542.1 Thousand | - | 1.36 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 9.51 Million | 193.74 Thousand | 66.88 Thousand | 2.93 Million | 416.09 Thousand | - |
Cost and Expenses | 11.68 Million | 1.91 Million | 3.11 Million | 12.49 Million | 21.58 Million | 3.84 Million |
Operating Income | -11.68 Million | -1.91 Million | -3.11 Million | -12.51 Million | -21.61 Million | -3.88 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 1.62 Million | 2.00 | -3.00 | -54.41 Thousand | -428.45 Thousand | -158.9 Thousand |
Earnings before Tax | -10.78 Million | -1.68 Million | -3.1 Million | -9.5 Million | -20.96 Million | -3.32 Million |
Net Income | -10.78 Million | -1.68 Million | -3.1 Million | -9.5 Million | -20.96 Million | -3.32 Million |
Earnings Per Share Basic | -0.09 | -0.02 | -0.03 | -0.11 | - | -0.04 |
Earnings Per Share Diluted | -0.09 | -0.02 | -0.03 | -0.11 | - | -0.04 |
Weighted Average Shares Outstanding | 118.36 Million | 105.61 Million | 100.86 Million | 85.96 Million | 74.16 Million | 88.62 Million |
Weighted Average Shares Outstanding (Diluted) | 118.36 Million | 105.61 Million | 100.86 Million | 85.96 Million | 74.16 Million | 88.62 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -11.65 Million | -1.88 Million | -3.08 Million | -12.48 Million | - | -3.88 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
DNAX
BZFD
TRTN-PC
CASH
9345
EPIGRAL